Phenytoin sodium and Memory loss - a phase IV clinical study of FDA data
Summary:
Memory loss is reported as a side effect among people who take Phenytoin sodium (phenytoin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Carbamazepine, and have Convulsion.
The phase IV clinical study analyzes which people have Memory loss when taking Phenytoin sodium. It is created by eHealthMe based on reports of 6,740 people who have side effects when taking Phenytoin sodium from the FDA, and is updated regularly.
What is Phenytoin sodium?
Phenytoin sodium has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 6,886 Phenytoin sodium users. Check the latest studies of Phenytoin sodium.
What is Memory loss?
Memory loss is found to be associated with 2,728 drugs and 4,377 conditions by eHealthMe. Check the latest studies of Memory loss.
6,740 people reported to have side effects when taking Phenytoin sodium.
Among them, 147 people (2.18%) have Memory loss.
Among these 147 people:
How long have people been on Phenytoin sodium when they have Memory loss? *
What is the gender of people who have Memory loss when taking Phenytoin sodium? *
What is the age of people who have Memory loss when taking Phenytoin sodium? *
What are other drugs people take besides Phenytoin sodium? *
What are other side effects people have besides Memory loss? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Phenytoin sodium and have Memory loss?
- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Phenytoin sodium:
- Phenytoin sodium (6,886 reports)
Memory loss treatments and more:
- Memory loss (244,444 reports)
How severe was Memory loss and when was it recovered:
Expand to all the drugs that have ingredients of phenytoin sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Phenytoin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Memory loss:
- Memory loss (2,728 drugs)
Browse all the conditions that are associated with Memory loss:
- Memory loss (4,377 conditions)
Related publications that referenced our studies
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on phenytoin sodium (the active ingredients of Phenytoin sodium) and Phenytoin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Budesonide and Thyroid Function Test Abnormal for Women aged 40-49 - 9 seconds ago
- Budesonide and Thyroid Disorder for Women aged 40-49 - 9 seconds ago
- Budesonide and Thyroide for Women aged 40-49 - 10 seconds ago
- Budesonide and Thyroid Diseases for Women aged 40-49 - 10 seconds ago
- Relapsing-Remitting Multiple Sclerosis and Head Injury - 13 seconds ago
- Drug interactions of Metadate Cd and Buspirone Hcl - 15 seconds ago
- Tiotropium Bromide and Bone Erosion for Women aged 60+ - 16 seconds ago
- Mycophenolate Mofetil and Mouth Ulceration for Men aged 60+ - 23 seconds ago
- Mycophenolate Mofetil and Ulcer - Mouth for Men aged 60+ - 23 seconds ago
- Mycophenolate Mofetil and Stomatitis - Ulcerative for Men aged 60+ - 24 seconds ago